Anti-new coronavirus drug Remdesivir to undergo phase 3 clinical trial in Wuhan - WritenAreGiven

WritenAreGiven

Technology: Latest News,Review & Leaks

Anti-new coronavirus drug Remdesivir to undergo phase 3 clinical trial in Wuhan

Share This
The first patient with a new type of coronavirus in the United States received injections of Remdesivir after his condition deteriorated, and his symptoms improved significantly the next day.

Anti-new coronavirus drug Remdesivir to undergo phase 3 clinical trial in Wuhan

Anti-new coronavirus drug Remdesivir to undergo phase 3 clinical trial in Wuhan

On January 31, the top medical journal "New England Medical Journal" (NEJM) published a paper online describing the patient's medical treatment, diagnosis, treatment and clinical manifestations, which caused a great sensation.

Remdesivir was previously a drug developed by Gilead for Ebola virus. It has not been marketed worldwide and cannot be used casually. It must undergo rigorous clinical trials to verify its safety and effectiveness in the new coronavirus.

At present, regarding the efficacy and safety of Remdesivir, Dr. Merdad Parsey, Gilead's global chief medical officer, issued a statement on behalf of the company. 

The company will cooperate with the Chinese health department to conduct a randomized, controlled trial, a phase III clinical trial in Wuhan. The sample size was as high as 270 cases. In theory, a carefully designed and executed large-scale randomized controlled clinical trial has the highest level of credibility, and it is also a very crucial step before formal application.

No comments:

Post a Comment

Like a Reply

Post Bottom Ad